Tuberculosis News and Research

Latest Tuberculosis News and Research

U.S. Congress has clear opportunity to supercharge global health R&D, shows report

The U.S. Congress and Biden-Harris administration have a clear opportunity to supercharge global health research and development (R&D) in the wake of a pandemic that has revealed both the sector's chronic neglect and amazing potential.

12 Mar 2021

Texas Biomed receives DoD subcontracts to assess SARS-CoV-2 decontamination technologies

Texas Biomedical Research Institute received two Department of Defense's (DoD) Defense Health Agency subcontracts to assess the efficacy of surface coating and aerosolized decontamination technologies to combat SARS-CoV-2 and other respiratory pathogens on surfaces and in the air.

11 Mar 2021

NIAID awards $2.5 million in grants to support research on bacteriophage therapy

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded $2.5 million in grants to 12 institutes around the world to support research on bacteriophage therapy.

11 Mar 2021

Critical mechanism allows deadly bacteria to gain resistance to antibiotics

Researchers have identified a critical mechanism that allows deadly bacteria to gain resistance to antibiotics.

9 Mar 2021

In-licensed candidate may be an effective intervention for premature infants with respiratory distress syndrome

The Lundquist Institute (TLI) and The Bill & Melinda Gates Medical Research Institute (Gates MRI) executed a license agreement for TLI intellectual property covering a synthetic lung surfactant formulation to be developed for respiratory distress syndrome (RDS) for premature infants in Low- and Middle-Income countries (LMIC).

8 Mar 2021

MUSC physician wins $9.9 million contract to run trials for the Tuberculosis Trials Consortium

Susan Dorman, M.D., an infectious disease physician at the Medical University of South Carolina, was recently awarded a 10-year, $9.9 million contract by the Centers for Disease Control and Prevention to run trials for the Tuberculosis Trials Consortium.

23 Feb 2021

Genetic mechanism enables TB-causing bacterium to remember and rapidly respond to stress

Tuberculosis bacteria have evolved to remember stressful encounters and react quickly to future stress, according to a study by computational bioengineers at Rice University and infectious disease experts at Rutgers New Jersey Medical School (NJMS).

22 Feb 2021

Human monoclonal antibodies can act as a substitute for traditional antibiotics

In the course of a new and groundbreaking study, led by Dr, Natalia Freund and the doctoral candidate Avia Waston at the Sackler Medical Faculty, the research group succeeded in isolating monoclonal antibodies, which hindered the growth of tuberculosis germs in laboratory mice. The

22 Feb 2021

Antimicrobial resistance to critical drugs spirals in low- and middle-income countries

As antibiotic use grows in lower-income countries so does antibiotic resistance, says report.

20 Feb 2021

New biomarker predicts individual anti-tuberculosis treatment duration

When can tuberculosis therapy be stopped without risk of relapse? Doctors are faced with this question time and again, because the lack of detection of the tuberculosis pathogen Mycobacterium tuberculosis is no guarantee for a permanent cure of the lung infection.

20 Feb 2021

Are antibody cocktails the key to COVID-19 treatment?

News-Medical speaks to Dr. Natalia Freund about her latest research into COVID-19, and how most people are capable of producing neutralizing antibodies against the virus.

18 Feb 2021

Tuberculosis vaccine could protect newborns against common infections

The tuberculosis (TB) vaccine Bacillus Calmette-Guerin (BCG) could protect newborns against a variety of common infections, such as upper respiratory tract infections, chest infections and diarrhoea, according to a new study in The Lancet Infectious Diseases.

18 Feb 2021

Duration of delirium in critically ill patients predicts mortality and disability

Delirium, a form of acute brain dysfunction, is widespread in critically ill patients in lower resourced hospitals, and the duration of delirium predicted both mortality and disability at six months after discharge, according to a study published in PLOS ONE.

11 Feb 2021

Tuberculosis News and Research

Latest Tuberculosis News and Research

U.S. Congress has clear opportunity to supercharge global health R&D, shows report

Texas Biomed receives DoD subcontracts to assess SARS-CoV-2 decontamination technologies

NIAID awards $2.5 million in grants to support research on bacteriophage therapy

Critical mechanism allows deadly bacteria to gain resistance to antibiotics

In-licensed candidate may be an effective intervention for premature infants with respiratory distress syndrome

MUSC physician wins $9.9 million contract to run trials for the Tuberculosis Trials Consortium

Genetic mechanism enables TB-causing bacterium to remember and rapidly respond to stress

Human monoclonal antibodies can act as a substitute for traditional antibiotics

Antimicrobial resistance to critical drugs spirals in low- and middle-income countries

New biomarker predicts individual anti-tuberculosis treatment duration

Are antibody cocktails the key to COVID-19 treatment?

Tuberculosis vaccine could protect newborns against common infections

Duration of delirium in critically ill patients predicts mortality and disability

Obesity, age and COVID-19 infection can make someone a super-spreader of SARS-CoV-2

New drug cocktail offers hope to patients with highly drug-resistant tuberculosis

Phase 1 clinical trial of novel HIV vaccine approach shows promising results

WHO revises definition of extensively drug-resistant tuberculosis

New study confirms the effectiveness of LDCT screening in a never-smoker high-risk population

Can the US keep covid variants in check? Here’s what it takes

R&D lacking on emerging infectious diseases, report finds

Breath Analysis: How Could it Improve Healthcare and Diagnosis?

Advancing the Diagnosis and Treatment of Ovarian Cancer

World Health Day 2021 – “Building a fairer, healthier world”

Tuberculosis News and Research

Latest Tuberculosis News and Research

Newsletters you may be interested in